Infliximab and Plant-Based Diet as First-Line Therapy Followed by Corticosteroid Therapy for Severe Ulcerative Colitis: A Case Report
We developed infliximab and a plant-based diet as first-line (IPF) therapies for severe ulcerative colitis (UC). It increased the remission rate and decreased the colectomy rate compared to those of current standards. We encountered a case with severe UC in which the consecutive use of IPF therapy a...
Main Authors: | Mitsuro Chiba, Tsuyotoshi Tsuji, Rie Masai, Masaru Odashima, Masato Sageshima |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Gastrointestinal Disorders |
Subjects: | |
Online Access: | https://www.mdpi.com/2624-5647/4/4/22 |
Similar Items
-
Protracted fever after infliximab induction therapy in a patient with ulcerative colitis (clinical case)
by: E. Yu. Chashkova, et al.
Published: (2022-12-01) -
Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review
by: Alix Démaris, et al.
Published: (2022-09-01) -
Prediction and Verification of Potential Therapeutic Targets for Non-Responders to Infliximab in Ulcerative Colitis
by: Lyu X, et al.
Published: (2023-05-01) -
Short-Term Response to Infliximab in Rheumatoid Pattern Polyarthropathy Complicating Ulcerative Colitis
by: ilke Coskun Benlidayi, et al.
Published: (2015-12-01) -
Steroid-Refractory Acute Severe Ulcerative Colitis in Infliximab-Experienced Patients
by: Joana Revés, et al.
Published: (2024-03-01)